Division 19 With regard to the notification of adverse events, the protocol shall identify the categories of:

adverse events or laboratory anomalies that are critical to safety evaluations and must be reported by the investigator to the sponsor, and

serious adverse events which do not require immediate reporting by the investigator to the sponsor.